Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin

BACKGROUND: Currently controversy exists about the immunogenicity of seasonal trivalent influenza vaccine in certain populations, especially the elderly. STF2.4×M2e (VAX102) is a recombinant fusion protein that links four copies of the ectodomain of influenza virus matrix protein 2 (M2e) antigen to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Talbot, H. Keipp, Rock, Michael T., Johnson, Casey, Tussey, Lynda, Kavita, Uma, Shanker, Anita, Shaw, Alan R., Taylor, David N.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2010
Assuntos:
Clinical Trial
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3010987/
https://ncbi.nlm.nih.gov/pubmed/21203437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0014442
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares